These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 30439478)

  • 21. Extracellular nucleotides and nucleosides induce proliferation and increase nucleoside transport in human glioma cell lines.
    Morrone FB; Jacques-Silva MC; Horn AP; Bernardi A; Schwartsmann G; Rodnight R; Lenz G
    J Neurooncol; 2003 Sep; 64(3):211-8. PubMed ID: 14558596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extracellular ATP: A Feasible Target for Cancer Therapy.
    Vultaggio-Poma V; Sarti AC; Di Virgilio F
    Cells; 2020 Nov; 9(11):. PubMed ID: 33212982
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ectonucleoside triphosphate diphosphohydrolases and ecto-5'-nucleotidase in purinergic signaling: how the field developed and where we are now.
    Zimmermann H
    Purinergic Signal; 2021 Mar; 17(1):117-125. PubMed ID: 33336318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNAs Modulate the Purinergic Signaling Network.
    Ferrari D; Bianchi N; Eltzschig HK; Gambari R
    Trends Mol Med; 2016 Oct; 22(10):905-918. PubMed ID: 27623176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. P2Y receptors for extracellular nucleotides: Contributions to cancer progression and therapeutic implications.
    Woods LT; Forti KM; Shanbhag VC; Camden JM; Weisman GA
    Biochem Pharmacol; 2021 May; 187():114406. PubMed ID: 33412103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ATP- and adenosine-mediated signaling in the central nervous system: adenosine receptor activation by ATP through rapid and localized generation of adenosine by ecto-nucleotidases.
    Matsuoka I; Ohkubo S
    J Pharmacol Sci; 2004 Feb; 94(2):95-9. PubMed ID: 14978343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms regulating airway nucleotides.
    Picher M
    Subcell Biochem; 2011; 55():17-49. PubMed ID: 21560043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pharmacological effects and metabolism of extracellular ATP].
    Nakazawa M
    Nihon Yakurigaku Zasshi; 1991 Sep; 98(3):235-43. PubMed ID: 1743602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Purinergic signalling in the musculoskeletal system.
    Burnstock G; Arnett TR; Orriss IR
    Purinergic Signal; 2013 Dec; 9(4):541-72. PubMed ID: 23943493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ecto-nucleotidases terminate purinergic signalling in the cochlear endolymphatic compartment.
    Vlajkovic SM; Thorne PR; Housley GD; Muñoz DJ; Kendrick IS
    Neuroreport; 1998 May; 9(7):1559-65. PubMed ID: 9631467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathological roles of purinergic signaling in the liver.
    Vaughn BP; Robson SC; Burnstock G
    J Hepatol; 2012 Oct; 57(4):916-20. PubMed ID: 22709619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Role of Purinergic Signaling in
    Ferla M; Tasca T
    Curr Top Med Chem; 2021; 21(3):181-192. PubMed ID: 32888270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Flow Cytometry of Membrane Purinoreceptors.
    Schwarz N; Junge M; Haag F; Koch-Nolte F
    Methods Mol Biol; 2020; 2041():117-136. PubMed ID: 31646484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Purinergic signaling in the pancreas and the therapeutic potential of ecto-nucleotidases in diabetes.
    Cieślak M; Roszek K
    Acta Biochim Pol; 2014; 61(4):655-62. PubMed ID: 25522227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Purinergic signaling, DAMPs, and inflammation.
    Di Virgilio F; Sarti AC; Coutinho-Silva R
    Am J Physiol Cell Physiol; 2020 May; 318(5):C832-C835. PubMed ID: 32159362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The roles of purinergic signaling in psychiatric disorders.
    Cieślak M; Czarnecka J; Roszek K
    Acta Biochim Pol; 2016; 63(1):1-9. PubMed ID: 26495439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Purinergic signalling in host innate immune defence against intracellular pathogens.
    Coutinho-Silva R; Savio LEB
    Biochem Pharmacol; 2021 May; 187():114405. PubMed ID: 33406411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Signalling by extracellular nucleotides in health and disease.
    Vultaggio-Poma V; Falzoni S; Salvi G; Giuliani AL; Di Virgilio F
    Biochim Biophys Acta Mol Cell Res; 2022 May; 1869(5):119237. PubMed ID: 35150807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interplay between purinergic signalling and extracellular vesicles in health and disease.
    Carotti V; Rigalli JP; van Asbeck-van der Wijst J; Hoenderop JGJ
    Biochem Pharmacol; 2022 Sep; 203():115192. PubMed ID: 35905971
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intracellular signalling by nucleotide receptors in PC12 pheochromocytoma cells.
    Raha S; de Souza LR; Reed JK
    J Cell Physiol; 1993 Mar; 154(3):623-30. PubMed ID: 8436608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.